Interleukin-15: Its role in microbial infections

Journal of Venomous Animals and Toxins Including Tropical Diseases

Volumn 13, Issue 3, 2007, Pages 562-575

  Bannwart, C F ^a   Nakaira, E T ^a   Sartori, A ^a   Peraçoli, Maria Terezinha Serrão ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Innate immunity; Interleukin 15; Microbial infections

Indexed keywords

EID: 34848881945     PISSN: 16789199     EISSN: 16789199     Source Type: Journal    
DOI: 10.1590/S1678-91992007000300002     Document Type: Review

References (57)

1. AHMAD A., SHARIF-ASKARI E., FAWAZ L., MENEZES J. Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction. J. Virol., 2000, 74, 7196-203.
2. ARMITAGE RJ., MACDUFF BM., EISENMAN J., PAXTON R., GRABSTEIN KH. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol., 1995, 154, 483-90.
3. ATEDZOE BN., AHMAD A., MENEZES J. Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction. J. Immunol., 1997, 159, 4966-72.
4. BADOLATO R., PONZI AN., MILLESIMO M., NOTARANGELO LD., MUSSO T. Interleukin (IL-15) induces IL-8 and monocyte chemotactic protein-1 production in human monocytes. Blood, 1997, 90, 2804-9.
5. BANNWART CF., MARTINS RAR., NAKAIRA ET., NASCIMENTO MPP., SOARES AMVC., PERAÇOLI MTS. Interleukin-15 enhances fungicidal activity of human monocytes infected in vitro with Paracoccidioides brasiliensis. J. Venom. Anim. Toxins incl. Trop. Dis. 2006, 12, 327.
6. BECKNELL B., CALIGIURI MA. Interleukin-2, interleukin-15 and their roles in human natural killer cells. Adv. Immunol., 2005, 86, 209-39.
7. BOUCHARD A., RATTHE C., GIRARD D. Interleukin-15 delays human neutrophils apoptosis by intracellular events and not via extracellular factors: role of Mcl-1 and decreased activity of caspase-3 and caspase-8. J. Leukoc. Biol., 2004, 75, 893-900.
8. BUDAGIAN V., BULANOVA E., ORINSKA Z., LUDWIG A., ROSE-JOHN S., SAFTIG P., BORDEN EC., BULFONE-PAUS S. Natural soluble interleukin-15R alpha is generated by cleavage that involves the tumor necrosis factor-alpha converting enzyme (TACE/ADAM17). J. Biol. Chem., 2004, 279, 40368-75.
9. BUDAGIAN V., BULANOVA E., PAUS R., BULFONE-PAUS S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev., 2006, 17, 259-80.
10. BULFONE-PAUS S., UNGUREANU D., POHL T., LINDNER G., PAUS R., RUCKERT R., KRAUSE H, RUNZENDORF U. Interleukin-15 protects from lethal apoptosis in vivo. Nat. Med., 1997, 3, 1124-8.
11. CARSON WE., CALIGIURI MA. Interleukin-15 is a potential regulator of the innate immune response. Brazilian J. Med. Biol. Res., 1998, 31, 1-9.
12. CARSON WE., GIRI JG., LINDERMANN MJ., LINETT ML., AHDIEH M., PAXTON R., ANDERSON D., EISENMANN J., GRABSTEIN K., CALIGIURI MA. Interleukin (IL-15) is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med., 1994, 180, 1395-403.
13. CARSON WE., ROSS ME., BAIOCCHI RA., MARIEN MJ., BOIANI M., GRABSTEIN K., CALIGIURI MA. Endogenous production of interleukin-15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J. Clin. Invest., 1995, 96, 2578-82.
14. CASSATELLA MA., MCDONALD PP. Interleukin-15 and its impact on neutrophil function. Curr. Opin. Hematol., 2000, 7, 174-7.
15. CHANG KH., KIM JM., KIM HY., SONG YG., CHOI YH., PARK YS., CHO JH., HONG SK. Spontaneous programmed cell death of peripheral blood mononuclear cells from HIV-infected persons is decreased with interleukin-15. Yonsei Med. J., 2000, 41, 112-8.
16. CHEHIMI J., MARSHALL JD., SALVUCCI O., FRANK I., CHEHIMI S., KAWECKI S., BACHELLER D., RIFAT S., CHOUAIB S. IL-15 enhances immune functions during HIV infection. J. Immunol., 1997, 158, 5978-87.
17. D'AGOSTINO P., MILANO S., ARCOLEO F., DI BELLA G., LA ROSA M., FERLAZZO V., CARUSO R., CHIFARI N., VITALE G., MANSUETO S., CILBARI E. Interleukin-15, as interferon-gamma, induces the killing of Leishmania infantum in phorbol-myristate-acetate-activated macrophages increasing interleukin-12. Scand. J. Immunol., 2004, 60, 609-14.
18. D'ETORRE G., CECCARELLI G., CARNEVALINI M., FORCINA G., ZAFFIRI L., MASSETTI AP., MASTROIANNI CM., VULLO V. Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis. Acta Trop., 2006, 99, 83-7.
19. ELLOSO MM., WALLACE M., MANNING DD., WEIDANZ WP. The effects of interleukin-15 on human gamma delta T cell responses to Plasmodium falciparum in vitro. Immunol. Lett., 1998, 64, 125-32.
20. FORCINA G., D'ETTORRE G., MASTROIANNI CM., CARNEVALINI M., SCORZOLINI L., CECCARELLI G., D'AGOSTINO C., LICHTNER M., MASSETTI AP., VULLO V. Interleukin-15 modulates interferon-gamma and beta-chemokine production in patients with HIV infection: implications for immune-based therapy. Cytokine, 2004, 25, 283-90.
21. GIRI JG., AHDIEH M., EISENMAN J., SHANEBECK K., GRABSTEIN KH., KUMAKI S., NAMEN A., PARK LS., COSMAN D., ANDERSON D. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J., 1994, 13, 2822-30.
22. GRABSTEIN KH., EISENMAN J., SHANEBECK KD., RAUCH C., SRINIVASAN S., FUNG V., BEERS C., RICHARDSON J., SCHOENBORN MA., AHDIEH M., JOHNSON L., ALDERSON MR., WATSON JD., ANDERSON DM., GIRI JG. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science, 1994, 264, 965-8.
23. HIROSE K., SUZUKI H., NISHIMURA H., MITANI A., WASHIZY J., MATSUGUCHI T., YOSHIKAI Y. Interleukin-15 may be responsible for early activation of intestinal intraepithelial lymphocytes after oral infection with Listeria monocytogenes in rats. Infect. Immun., 1998, 66, 5677-83.
24. HOONTRAKOON R., CHU WH., GARDAI SJ., WENZEL SE., MCDONALD P., FADOK VA., HENSON PM., BRATTON DL. Interleukin-15 inhibits spontaneous apoptosis in human eosinophils via autocrine production of granulocyte macrophagecolony stimulation factor and nuclear factor-kB activation. Am. J. Respir. Cell. Mol. Biol., 2002, 26, 404-12.
25. HUNTER CA., ELLIS-NEYER L., GABRIEL KE., KENNEDY MK., GRABSTEIN KH., LINSLEY PS., REMINGTON JS. The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii. J. Immunol., 1997, 158, 2285-93.
26. JAMES SL., NACY C. Effector functions of activated macrophages against parasites. Curr. Opin. Immunol., 1993, 5, 518-24.
27. JOHNSTON JA., BACON CM., FINBLOOM DS., REES RC., KAPLAN D., SHIBUYA K., ORTALDO JR., GUPTA S., CHEN YO., GIRI JD. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc. Natl. Acad. Sci. USA, 1995, 92, 8705-9.
28. JULLIEN D., SIELING PA., UYEMURA K., MAR ND., REA TH., MODLIN RL. IL-15 an immunomodulator of T cell responses in intracellular infection. J. Immunol., 1997, 158, 800-6.
29. KAKUMU S., OKUMURA A., ISHIKAWA T., YANO M., ENOMOTO A., NISHIMURA H., YOSHIOKA K., YOSHIKAI Y. Serum levels of IL-10, IL-15 and soluble tumor necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease. Clin. Exp. Immunol., 1997, 109, 458-63.
30. KHAN IA., KASPER LH. IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice. J. Immunol., 1996, 157, 2103-8.
31. KIM HS., CHOI EH., KHAN J., ROILIDES E., FRANCESCONI A., KASAI M., SEINT T., SCHAUFELE RL., SAKURAI K., SON CG., GREER BT., CHANOCK S., LYMAN CA., WALSH TJ. Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect. Immun., 2005, 73, 3714-24.
32. LEONARD WJ. Role of JAK kinases and STATs in cytokine signal transduction. Int. J. Hematol., 2001, 73, 271-7.
33. LEONARD WJ., SHORES EW., LOVE PE. Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development. Immunol. Rev., 1995, 148, 97-114.
34. LODOLCE JP., BURKETT PR., KOKA RM., BOONE DL., MA A. Regulation of lymphoid homeostasis by interleukin-15. Cytokine Grow Factor Rev., 2002, 13, 429-39.
35. MA A., KOKA R., BURKETT P. Diverse functions of IL-2, IL-15 and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol., 2006, 24, 657-79.
36. MA LL., SPURRELL JC., WANG JF., NEELY GG., EPELMAN S., KRENSKY AM., MODY CH. CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15. J. Immunol., 2002, 169, 5787-95.
37. McDONALD PP., RUSSO MP., FERRINI S., CASSATELA MA. Interleukin-15 induces NF-kappaB activation and IL-8 production in human neutrophils. Blood, 1998, 92, 4828-35.
38. MAEURER MJ., TRINDER P., HOMMEL G., WALTER W., FREITAG K., ATKINS D., STORKEL S. Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice. Infect. Immun., 2000, 68, 2962-70.
39. MATTEI F., SCHIAVONI G., BELARDELLI F., TOUGH DF. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA or lipopolysaccharide and promotes dendritic cell activation. J. Immunol., 2001, 167, 1179-87.
40. MIZUNO Y. Host defense mechanisms against Salmonella infection. Nihon Rinsho Meneki Gakkai Kaishi, 2004, 27, 367-72.
41. MODY CH., SPURREL JC., WODD CJ. Interleukin-15 induces antimicrobial activity after release by Criptococcus neoformans-stimulated monocytes. J. Infect. Dis., 1998, 178, 803-14.
42. MORTIER E., BERNARD J., PLET A., JACQUES Y. Natural proteolytic release of a soluble form of human IL-15 receptor α-chain that behaves as a specific, high affinity IL-15 antagonist. J. Immunol., 2004, 173, 1681-8.
43. MUSSO T., CALOSSO L., ZUCCA M., MILLESIMO M., RAVARINO D., GIOVARELLI M., MALAVASI F., PONZI NA., PAUS R., BULFONE-PAUS S. Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood, 1999, 93, 3531-9.
44. NEELY GG., EPELMAN S., MA LL., COLARUSSO P., HOWLETT CJ., AMANKWAH EK., McINTIRE AC., ROBBINS SM., MODY CH. Monocytes surface-bound IL-15 can function as an activating receptor and participate in reverse signaling. J. Immunol., 2004, 172, 4225-34.
45. NISHIMURA H., HIROMATSU K., KOBAYASHI N., GRABSTEIN KH., PAXTON R., SAGAMURA K., BLUESTONE JA., YOSHIKAI Y. IL-15 in a novel growth for murine gamma delta T cells induced by Salmonella infection. J. Immunol., 1996, 156, 663-9.
46. OHTEKI T., SUZUE K., MAKI C., OTA T., KOYASU S. Critical role of IL-15- IL-15R for antigen-presenting cell functions in the innate immune response. Nat. Immunol., 2001, 2, 1138-43.
47. PARK CS., YOON SO., ARMITAGE RJ., CHOI YS. Follicular dendritic cells produce IL-15 that enhances germinal center B cell proliferation in membrane-bound form. J. Immunol., 2004, 173, 6676-83.
48. RATTHE C., GIRARD D.. Interleukin-15 enhances human neutrophils phagocytosis by a Syk-dependent mechanism: importance of the IL-15R alpha chain. J. Leukoc. Biol., 2004, 76, 162-8.
49. TAGAYA Y., BURTON JD., MIYAMOTO Y., WALDMANN TA. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J., 1996, 15, 4928-39.
50. TAKANO M., NISHIMURA H., KIMURA Y., MOKUNO Y., WASHIZU J., ITOHARA S., NIMURA Y., YOSHIKAI Y. Protective roles of gamma delta T cells and interleukin-15 in Escherichia coli infection in mice. Infect. Immun., 1998, 66, 3270-10.
51. TAVIAN EG., DIAS-MELICIO LA., BORDON AP., ACORCI MJ., BIONDO GA., PERAÇOLI MT., SOARES AMVC. Effect of IL-15 on fungicidal activity and H2O2 release by human neutrophils challenged with high virulent strain of Paracoccidioides brasiliensis. J. Venom. Anim. Toxins incl. Trop. Dis., 2006, 12, 340.
52. TRAN P., AHMAD R., XU J., AHMAD A., MENEZES J. Host's innate immune response to fungal and bacterial agents in vitro: up-regulation of interleukin-15 gene expression resulting in enhanced natural killer activity. Immunology, 2003, 109, 263-70.
53. VAN BELLE T., GROOTEN J. IL-15 and IL-15Rα in CD4+ T cell immunity. Arch. Immunol. Ther. Exp. (Warsz), 2005, 53, 115-26.
54. VAZQUEZ N., WALSH TJ., FRIEDMAN D., CHANOCK SJ., LYMAN CA. Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. Infect. Immun., 1998, 66, 145-50.
55. WALDMANN TA., TAGAYA Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol., 1999, 17, 19-49.
56. WINN RM., GIL-LAMAIGNERE C., ROILIDES E., SIMITSOPOULOU M., LYMAN CA., MALOUKOU A., WALSH TJ. Selective effects of interleukin (IL)-15 on antifungal activity and IL-8 release by polymorphonuclear leukocytes in response to hyphae of Aspergillus species. J. Infect. Dis., 2003, 188, 585-90.
57. YOSHIKAI Y., NISHIMURA H. The role of interleukin-15 in mounting an immune response against microbial infection. Microbes Infect., 2000, 2, 381-9.